parotid oncocytoma as a manifestation of birt-hogg-dubé syndrome

Clicks: 101
ID: 195961
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #28 of 36 articles by views in faṣlnāmah-i pizhūhish/hā-yi rāhburdī-i siyāsat

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disease characterized by skin fibrofolliculomas, pulmonary cysts, spontaneous pneumothoraces, and renal cancers. Oncocytomas are benign epithelial tumors that are also rare. Recently, there have been a few case reports of BHD with a parotid oncocytoma that appears to have a BHD phenotype. Here we document the eighth known case and describe the magnetic resonance imaging features of the parotid oncocytoma, which mimicked Warthin’s tumor. Radiologists should be aware of the association between these rare disorders.
Reference Key
yoshida2018caseparotid Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Kazuki Yoshida;Masao Miyagawa;Teruhito Kido;Kana Ide;Yoshifumi Sano;Yoshifumi Sugawara;Hiroyuki Takahata;Nobuya Monden;Mitsuko Furuya;Teruhito Mochizuki
Journal faṣlnāmah-i pizhūhish/hā-yi rāhburdī-i siyāsat
Year 2018
DOI
10.1155/2018/6265175
URL
http://dx.doi.org/10.1155/2018/6265175
Keywords
medical physics nuclear medicine medical radiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.